Pseudopolymorphic Forms Of A Hiv Protease Inhibitor

Patent No. EP2767539 (titled "Pseudopolymorphic Forms Of A Hiv Protease Inhibitor") was filed by Janssen R&D Ireland on May 16, 2003. The application was issued on Jul 12, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
COOKEApr 12, 2018ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2767539

JANSSEN R&D IRELAND
Application Number
EP14168686A
Filing Date
May 16, 2003
Status
Opposition Rejected
Feb 10, 2023
Publication Date
Jul 12, 2017